Treatment with N-acetylcysteine (NAC) blocked mTOR (which is extensively linked with AhR, details in 5.5) in T lymphocytes and significantly reduced Kyn levels in patients, suggesting a therapeutic role in SLE (169). This evidence concerns the gene MTOR and systemic lupus erythematosus.